On September 22, at the 2026 Nuclear Technology Application and Nuclear Medical Industry Innovation and Development Conference held in Mianyang City, Sichuan Province released a series of documents relating to high-quality development of nuclear technology and industry, medium- and long-term development plans for the controlled nuclear fusion industry, and the “15th Five-Year Plan” for the development of the nuclear medical industry. It is proposed that the scale of the province's nuclear industry will exceed 200 billion yuan by 2030. Sichuan is a major province for the nuclear industry and the use of nuclear technology. It has now established a whole industry chain of “nuclides - nuclear drugs - nuclear medical equipment - clinical application”. “We have explored the 'Innovative Platform Selection and Transformation+Early Investment of Science and Technology Venture Capital Companies' Achievement Transformation Model. We have converted 52 nuclear medical research achievements in Mianyang, achieved 27 put into operation, and 7 products have been approved as the first set of products in the province.” Han Xiaoqing, deputy director of the Mianyang Science and Technology City Management Committee, said. According to a series of documents, by 2030, Sichuan will cultivate more than 2 leading enterprises at the 10 billion level, and the direct economic output value of the nuclear medical industry will exceed 30 billion yuan; accelerate research on key core technologies and demonstration applications in non-power generation scenarios around nuclear fusion energy, and build a first-class domestic controlled nuclear fusion industry cluster area.

On September 22, at the 2026 Nuclear Technology Application and Nuclear Medical Industry Innovation and Development Conference held in Mianyang City, Sichuan Province released a series of documents relating to high-quality development of nuclear technology and industry, medium- and long-term development plans for the controlled nuclear fusion industry, and the “15th Five-Year Plan” for the development of the nuclear medical industry. It is proposed that the scale of the province's nuclear industry will exceed 200 billion yuan by 2030. Sichuan is a major province for the nuclear industry and the use of nuclear technology. It has now established a whole industry chain of “nuclides - nuclear drugs - nuclear medical equipment - clinical application”. “We have explored the 'Innovative Platform Selection and Transformation+Early Investment of Science and Technology Venture Capital Companies' Achievement Transformation Model. We have converted 52 nuclear medical research achievements in Mianyang, achieved 27 put into operation, and 7 products have been approved as the first set of products in the province.” Han Xiaoqing, deputy director of the Mianyang Science and Technology City Management Committee, said. According to a series of documents, by 2030, Sichuan will cultivate more than 2 leading enterprises at the 10 billion level, and the direct economic output value of the nuclear medical industry will exceed 30 billion yuan; accelerate research on key core technologies and demonstration applications in non-power generation scenarios around nuclear fusion energy, and build a first-class domestic controlled nuclear fusion industry cluster area.